Mechanistic insight into the oxazoline decomposition of DFC-M, a synthetic intermediate of florfenicol.

J Pharm Biomed Anal

Analytical Research & Development, Merck & Co. Inc., Rahway, NJ, 07065, United States. Electronic address:

Published: September 2019

2-(dichloromethyl)-5[4-(methylsulfonyl)-phenyl]-4-(fluoromethyl)-oxazoline (DFC-M, 1) is a key oxazoline-containing intermediate in commercial process for the synthesis of Florfenicol (3), a marketed broad spectrum veterinary antibiotic. DFC-M was not stable in solution due to the presence of oxazoline moiety, which provided further hindrance for analytical sample preparation and HPLC analysis. Hence, the mechanistic study on the in-solution degradation of DFC-M was carried out via online and offline UPLC-HR-ESI-MS as well as in-situ NMR, and the degradation pathways were proposed. This mechanistic information, together with the follow-up solution stability study, provided crucial information regarding the solution handling and mobile phase selection for DFC-M analysis during commercial processing.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2019.05.009DOI Listing

Publication Analysis

Top Keywords

dfc-m
5
mechanistic insight
4
insight oxazoline
4
oxazoline decomposition
4
decomposition dfc-m
4
dfc-m synthetic
4
synthetic intermediate
4
intermediate florfenicol
4
florfenicol 2-dichloromethyl-5[4-methylsulfonyl-phenyl]-4-fluoromethyl-oxazoline
4
2-dichloromethyl-5[4-methylsulfonyl-phenyl]-4-fluoromethyl-oxazoline dfc-m
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!